Bill Maris, the founder and former CEO of Google Ventures (later renamed GV) who left the company earlier this year, has reportedly raised $230 million for a new fund that will focus on healthcare investments.
As Recode reports, sources close to Maris said regulatory filings related to the funding will be released as early as this week. The fund is called Section 32, and will largely be run by Maris himself and will operate primarily out of San Diego.
Maris founded GV in 2009. In August of this year, he stepped down as CEO, and told Fortune that during his eight years at GV it had become a “preeminent VC fund.” His departure marked the one-year anniversary of the creation of Alphabet, the holding company of Google that was established to distinguish projects like GV from core Google business.
During his time at GV, Maris, who studied neuroscience, showed a lot of interest in healthcare. Maris and GV worked with Flatiron Health, Foundation Medicine, FitStar, Doctor on Demand, One Medical and Spruce. As of last spring, Google Ventures had invested about 30 percent of its annual $300 million fund into health startups.
While it’s not known exactly what parts of healthcare Section 32 will focus on, Maris has previously shown interest in age-related diseases and cancer, Fortune reports.